Giulia Gasparini

Dr. Giulia Gasparini

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2019 in Cancers
Verified
Journal Article
Open access
PDF file
GGGiulia Gasparini
Giulia Gasparini
MPMarta Pellegatta
Marta Pellegatta
SCStefano Crippa
Stefano Crippa
MLMarco Schiavo Lena
Marco Schiavo Lena
GBGiulio Belfiori
Giulio Belfiori
MFMassimo Falconi
Massimo Falconi
Perineural invasion (PNI) is defined as the presence of neoplastic cells along nerves and/or within the different layers of nervous fibers: epineural, perineural and endoneural spaces. In pancreatic cancer—particularly in pancreatic ductal adenocarcinoma (PDAC)—PNI has a prevalence between 70 and 100%, surpassing any other solid tumor. PNI has been detected in the early stages of pancreatic cancer and has been associated with pain, increased tumor recurrence and diminished overall survival. Such an early, invasive and recurrent phenomenon is probably crucial for tumor growth and metastasis. PNI is a still not a uniformly characterized event; usually it is described only dichotomously (“present” or “absent”). Recently, a more detailed scoring system for PNI has been proposed, though not specific for pancreatic cancer. Previous studies have implicated several molecules and pathways in PNI, among which are secreted neurotrophins, chemokines and inflammatory cells. However, the mechanisms underlying PNI are poorly understood and several aspects are actively being investigated. In this review, we will discuss the main molecules and signaling pathways implicated in PNI and their roles in the PDAC.

22 January 2019 in Gastroenterology Research and Practice
Verified
Journal Article
Open access
PDF file
EOElena Orsenigo
Elena Orsenigo
GGGiulia Gasparini
Giulia Gasparini
MCMichele Carlucci
Michele Carlucci
Many colorectal resections do not meet the minimum of 12 lymph nodes (LNs) recommended by the American Joint Committee on Cancer for accurate staging of colorectal cancer. The aim of this study was to investigate factors affecting the number of the adequate nodal yield in colorectal specimens subject to routine pathological assessment. We have retrospectively analysed the data of 2319 curatively resected colorectal cancer patients in San Raffaele Scientific Institute, Milan, between 1993 and 2017 (1259 colon cancer patients and 675 rectal cancer patients plus 385 rectal cancer patients who underwent neoadjuvant therapy). The factors influencing lymph node retrieval were subjected to uni- and multivariate analyses. Moreover, a survival analysis was carried out to verify the prognostic implications of nodal counts. The mean number of evaluated nodes was 24.08±11.4, 20.34±11.8, and 15.33±9.64 in surgically treated right-sided colon cancer, left-sided colon cancer, and rectal tumors, respectively. More than 12 lymph nodes were reported in surgical specimens in 1094 (86.9%) cases in the colon cohort and in 425 (63%) cases in the rectal cohort, and patients who underwent neoadjuvant chemoradiation were analysed separately. On univariate analysis of the colon cancer group, higher LNs counts were associated with female sex, right colon cancer, emergency surgery, pT3-T4 diseases, higher tumor size, and resected specimen length. On multivariate analysis right colon tumors, larger mean size of tumor, length of specimen, pT3-T4 disease, and female sex were found to significantly affect lymph node retrieval. Colon cancer patients with 12 or more lymph nodes removed had a significantly better long-term survival than those with 11 or fewer nodes (P=0.002, log-rank test). Rectal cancer patients with 12 or more lymph nodes removed approached but did not reach a statistically different survival (P=0.055, log-rank test). Multiple tumor and patients’ factors are associated with lymph node yield, but only the removal of at least 12 lymph nodes will reliably determine lymph node status.

13 February 2023 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
GGGiovanni Guarneri
Giovanni Guarneri
NPNicolò Pecorelli
Nicolò Pecorelli
ABAndrea Bettinelli
Andrea Bettinelli
ACAntonino Campisi
Antonino Campisi
DPDiego Palumbo
Diego Palumbo
MFMassimo Falconi
Massimo Falconi

1 March 2019 in La Presse Médicale
Verified
Journal Article
Closed access
GGGiovanni Guarneri
Giovanni Guarneri
GGGiulia Gasparini
Giulia Gasparini
SCStefano Crippa
Stefano Crippa
VAValentina Andreasi
Valentina Andreasi
MFMassimo Falconi
Massimo Falconi

1 August 2020 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
SCStefano Crippa
Stefano Crippa
GGGiovanni Guarneri
Giovanni Guarneri
GBGiulio Belfiori
Giulio Belfiori
SPStefano Partelli
Stefano Partelli
MPMichele Pagnanelli
Michele Pagnanelli
MFMassimo Falconi
Massimo Falconi

1 June 2021 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
SCStefano Crippa
Stefano Crippa
CRClaudio Ricci
Claudio Ricci
GGGiovanni Guarneri
Giovanni Guarneri
CICarlo Ingaldi
Carlo Ingaldi
GGGiulia Gasparini
Giulia Gasparini
MFMassimo Falconi
Massimo Falconi